Quetiapine Augmentation for Treatment-resistant PTSD

Clinical trial NCT00292370 · COMPLETED

Trial details

NCT number: NCT00292370
Sponsor: VA Office of Research and Development
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Combat Disorders Stress Disorders, Post-Traumatic

Start date: 2006-01-01
Primary completion: 2008-12-01
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.